These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 21389187

  • 1. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
    Gorantla B, Asuthkar S, Rao JS, Patel J, Gondi CS.
    Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
    [Abstract] [Full Text] [Related]

  • 2. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R, Chetty C, Bhoopathi P, Lakka S, Mohanam S, Rao JS, Dinh DE.
    Int J Oncol; 2011 Mar 01; 38(3):733-44. PubMed ID: 21181094
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC.
    Pancreas; 2008 Mar 01; 36(2):160-7. PubMed ID: 18376307
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 6. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Feb 20; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 7. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Oncogene; 2003 Sep 04; 22(38):5967-75. PubMed ID: 12955075
    [Abstract] [Full Text] [Related]

  • 8. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines.
    Raghu H, Lakka SS, Gondi CS, Mohanam S, Dinh DH, Gujrati M, Rao JS.
    PLoS One; 2010 Aug 27; 5(8):e12458. PubMed ID: 20805979
    [Abstract] [Full Text] [Related]

  • 9. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R, Gondi CS, Lakka SS, Jutla A, Rao JS.
    Int J Oncol; 2006 Apr 27; 28(4):831-9. PubMed ID: 16525631
    [Abstract] [Full Text] [Related]

  • 10. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec 27; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 11. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 27; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB, Taylor M, Grøndahl-Hansen J, Kakolyris S, Gatter KC, Harris AL.
    J Pathol; 2001 Sep 27; 195(2):236-43. PubMed ID: 11592104
    [Abstract] [Full Text] [Related]

  • 13. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Clin Cancer Res; 2007 Jul 15; 13(14):4051-60. PubMed ID: 17634529
    [Abstract] [Full Text] [Related]

  • 14. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.
    Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513
    [Abstract] [Full Text] [Related]

  • 15. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 01; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 16. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
    Iwamoto J, Mizokami Y, Takahashi K, Matsuoka T, Matsuzaki Y.
    Helicobacter; 2008 Jun 01; 13(3):174-82. PubMed ID: 18466392
    [Abstract] [Full Text] [Related]

  • 17. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH, Mazar A, Henkin J, Rabbani SA.
    Cancer Res; 1997 Aug 15; 57(16):3585-93. PubMed ID: 9270032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
    Harvey SR, Hurd TC, Markus G, Martinick MI, Penetrante RM, Tan D, Venkataraman P, DeSouza N, Sait SN, Driscoll DL, Gibbs JF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4935-43. PubMed ID: 14581368
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS.
    Cancer Res; 2004 Jun 15; 64(12):4069-77. PubMed ID: 15205313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.